Alteration of glucose, insulin, TG, HDLch and LDL values and cardiovascular problems are also indicated in other original studies or meta-analyses on MS from NAFLD [2,4,10,11,18,50,51]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.